UNSPSC 85491853: Bypass coronary artery, four or more sites from coronary vein with drug-eluting intraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass coronary artery, four or more sites from coronary vein with drug-eluting intraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 213344

UNSPSC 85491853 Bypass coronary artery, four or more sites from coronary vein with drug-eluting intraluminal device, percutaneous approach is a Commodity code that shows minimal relevant recent activity under state and local procurement. The six recent opportunities posted under this code span independent medical evaluation services, pharmacy benefit management, occupational medical surveillance, surgical benefit carve-out programs for government employee health plans, specialty medical services for detained youth, and temporary health professional staffing — none of which represent procurement of the cardiac device or procedure specified by the code's nominal scope. The issuing bodies include a city retirement office, a county board of commissioners, a state transportation department, a county juvenile probation department, a county health system, and a city human resources department. The geographic spread covers Arizona, California, Florida, Texas, and Washington.

The mismatch between the code's stated scope and the actual solicitations indicates that this Commodity code does not align with genuine state and local procurement activity for bypass coronary artery devices or related cardiac procedures. Businesses pursuing medical device sales or cardiac procedure services should verify whether state and local procurement offices use this code for their actual buying activity, or whether a different UNSPSC classification better reflects how these jurisdictions tag cardiovascular and interventional cardiology purchasing. The recent opportunities on record do not represent addressable market under this code's intended taxonomy.